Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Funding Announcements: February 2013

The following new grants were awarded to JCCC members, announced in February 2013:

Principal Investigator: Baum, Linda

Sponsor Name: Muscular Dystrophy Assoc. of America, Inc.

Award Title: Human Skeletal Muscle Cell Glycome-Structures and Functions

Principal Investigator: Christofk, Heather

Sponsor Name: University of Southern California

Award Title: Exploring a Potential Metabolic Mechanism of Drug Resistance

Principal Investigator: Eradat, Herbert

Sponsor Name: Millennium Pharmaceuticals, Inc.

Award Title: Randomized, Open-Label, Phase 3 Trial of Brentuximab Vedotin (SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients with CD30-Positive Cutaneous T-Cell Lymphoma

Principal Investigator: Finn, Richard

Sponsor Name: Gilead Sciences, Inc.

Award Title: Pre-Clinical Research Program To Evaluate Potential Translational Science for Gilead SYK Inhibitor

Principal Investigator: Gasson, Judith

Sponsor Name: Not Available

Award Title: Rivals United for a Kure

Principal Investigator: Henning, Susanne

Sponsor Name: NIH/National Cancer Institute

Award Title: Quercetin To Enhance the Bioavailability and activity of Green Tea Polyphenols

Principal Investigator: Jung, Michael

Sponsor Name: Brentwood Biomedical Research Institute (Va Fdn.)

Award Title: Dysregulation of Mtor2 in Gliomas

Principal Investigator: Kitchen, Scott

Sponsor Name: UC California HIV/AIDS Research Program

Award Title: Novel Functions of Human Immunodeficiency Virus Protein

Principal Investigator: Lo, Roger

Sponsor Name: Harry J. Lloyd Charitable Trus

Award Title: Overcoming Distinct Mechanisms of Acquired B-RaF Inhibitor Resistance in Melanoma Patients by Rational Combinational Targeting

Principal Investigator: Mitsuyasu, Ronald

Sponsor Name: Calimmune, Inc.

Award Title: Adaptive Phase I/II Study of the Safety of Cd4+ T Lymphocytes and Cd34+ Hematopoietic Stem/Progenitor Cells Transduced with Lvsh5/C46, a Dual Anti-HIV Gene Transfer Construct with/without Conditioning with Busulfan in HIV-1 Infected Adults Previously Exposed to Art

Principal Investigator: Nelson, Stanley

Sponsor Name: Cal Institute for Regenerative Medicine (CIRM)

Award Title: Combination Therapy to Enhance antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy

Principal Investigator: Pietras, Richard

Sponsor Name: NIH/Center for Scientific Review

Award Title: Development of New therapeutics for Pancreatic Cancer Management

Principal Investigator: Pothoulakis, Charalabos

Sponsor Name: Optimer Pharmaceuticals, Inc.

Award Title: Effect of Vancomycin and Metronidazole in Toxin a-Mediated Inflammatory Responses in Mouse Ileal Loops In Vivo

Principal Investigator: Ribas, Antoni

Sponsor Name: University of Texas, Houston

Award Title: Immunologic Checkpoint Blockade and adoptive Cell Transfer in Cancer Therapy

Principal Investigator: Rowat, Amy

Sponsor Name: National Science Foundation

Award Title: Career: Mechanotyping Platform for Studies of Soft Biological Matter

Principal Investigator: Segura, Tatiana

Sponsor Name: Cal Institute for Regenerative Medicine (CIRM)

Award Title: Design of Cell Instructive Materials

Principal Investigator: Tseng, Hsian-Rong

Sponsor Name: NIH/National Cancer Institute

Award Title: Molecular and Functional analysis of Single Circulating Melanoma Cells

 

Last updated: 5/29/2013 3:52:37 PM